HYDERABAD: No more painful injections or oral drugs for patients suffering with diseases like cancer and rheumatoid arthritis. Now, patients can apply a transdermal patch on their skin and get relieved from the dreadful pain for at least three days.
For the first time in India, the city-based Sparsha Pharma International Private Limited is all set to launch pain treatment products developed and manufactured using Transdermal Drug Delivery System (TDDS). Earlier, drugs were introduced into the body using injections and oral drugs. The TDDS is a new method of releasing certain drugs into the body of the patient using a patch.
“The new method is less painful, affordable and more effective than other methods of drug delivery. Further, manufacturing of this product indigenously reduces the high cost of importing and will become affordable for all,” Sparsha Pharma managing director Dange Veerapaneni said. Such patch products are currently being imported from abroad and are available at about Rs 400 each.
However, manufacturing the product indigenously would reduce the cost by 50 per cent.
Sparsha Pharma is likely to introduce the TDDS patches in the market by March.
Chief Minister YS Rajasekhara Reddy formally announced the openeing of the state-of-the-art facility of Sparsha Pharma International Private Limited at a function held in the city today. The manufacturing unit has been set-up at Muppireddypalli village in Medak district .